Home
Portolan Capital Management reported a 4.45% stake in Castle Biosciences CSTL · 1,350,283 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.45%
- Last report
- 5.65% · filed 25/04/14
- Shares held
- 1,350,283 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 26/03/31
- Filed
- 26/05/15
4.45% stake · below 5%
- Stake
- 4.45%
- Last report
- 5.65%
- Since last report
- −1.2pp
Castle Biosciences trades, last 26 weeks
What else happened in Castle Biosciences around then
Filed or reported within 30 days of the trade day · 03/01~04/30Portolan Capital Management's other 5% stake reports
- Portolan Capital Management
5% stakeSilicom
5% stakeSilicom
SILC
5.06% stake
288,787 sh
5.06% stake
Filed 09/30
- Portolan Capital Management
5% stakeQuanterix
5% stakeQuanterix
QTRX
4.02% stake
1,899,308 sh
4.02% stake
Filed 08/14
- Portolan Capital Management
5% stakeTecogen
5% stakeTecogen
TGEN
5.19% stake
1,552,232 sh
5.19% stake
Filed 06/10
- Portolan Capital Management
5% stakeMayville Engineering Company
5% stakeMayville Engineering Company
MEC
5.92% stake
1,465,004 sh
5.92% stake
Filed 05/28
- Portolan Capital Management
5% stakeVishay Precision Group
5% stakeVishay Precision Group
VPG
8.31% stake
1,019,868 sh
8.31% stake
Filed 05/15
